The weekly litigation news digest is live. Subscribe now
Process Of Spray Drying Of Glp-1 Peptide - EP3897582
The patent EP3897582 was granted to Novo Nordisk on Sep 11, 2024. The application was originally filed on Dec 20, 2019 under application number EP19828757A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP3897582
- Application Number
- EP19828757A
- Filing Date
- Dec 20, 2019
- Status
- Granted And Under Opposition
- Aug 8, 2024
- Publication Date
- Sep 11, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
A process for spray drying semaglutide, a GLP-1 peptide, that achieves improved yield by controlling the ratio of atomizing gas flow rate to feed flow rate. The process involves introducing the semaglutide solution into a spray dryer at a feed flow rate and introducing an atomizing gas at a flow rate that maintains a ratio of 1.0-1.7, independent of the apparatus used or outlet temperature. This optimized ratio enables reduced product loss and higher yield compared to conventional spray drying processes.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (11) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents